Success Rates of E-Cigarettes and Nicotine Patches are Comparable.

logo1267406_mdA new study presented at the European Respiratory Society (ERS) Annual Congress in Barcelona, Spain and published in the Lancet conclude that e-cigarette and nicotine patches have comparable success in quitting, with similar proportions of smokers who used either method remaining abstinent from smoking for six months after a 13 week course of patches ore e-cigarettes.

Sin hundred fifty seven study participants (smokers) were recruited and all wanted to quit smoking and were divided into 3 groups. Group one of 292 subjects received 13 weeks supply of e-cigatettes, each of which contained around 16 mg of nicotine. The same number (292 subjects) received 13 weeks supply of nicotine patches. The third group of 73 subjects received placebo e-cigarettes which contained no nicotine.

Over the 13 weeks and for 3 months after  participants were tested to establish whether or no0t they had remained abstinent from cigarettes. At the end of the 6 month period, about 1 in twenty of the subjects (5.7%) managed to remain completely abstinent from smoking. Although more of the e-cigarette group (7.3%) remained abstinet, compared to the nicotine group (5.3%) and the controls or placebio e-cigarette group (4.1%) there was no signifant difference in the groups. Among those who continued smoking there was a marked reduction in smoking in the e-cigarette group compared to the patches and placebo groups and over half (57%) of the e-cigarette group had reduced their daily consumption of cigarettes by at least half after 6 months compared to just over two fifths (31%) of the patch group.

Researchers said: “Our study establishes a critical benchmark for e-cigarette performance compared to nicortine patches and placebl e-cigarettes, but there is still so much that is unknown about the effectiveness and long-term effects of e-cigarettes. Given the increasing popularity of these devices in many countries, and the accompanying regulatory uncertainty and inconsistency, larger, longer-term trials are urgently needed to establish whether these devices might be able to fufill their potential as effective and popular smoking cessation aids.”

 

Comments are closed.